468
Participants
Start Date
February 17, 2021
Primary Completion Date
January 11, 2024
Study Completion Date
February 27, 2026
Nivolumab
Specified dose on specified days
Relatlimab
Specified dose on specified days
Carboplatin
Specified dose on specified days. Participant will receive only two of the listed chemotherapies (carboplatin, cisplatin, paclitaxel, nab-paclitaxel) along with immunotherapy.
Cisplatin
Specified dose on specified days. Participant will receive only two of the listed chemotherapies (carboplatin, cisplatin, paclitaxel, nab-paclitaxel) along with immunotherapy.
Paclitaxel
Specified dose on specified days. Participant will receive only two of the listed chemotherapies (carboplatin, cisplatin, paclitaxel, nab-paclitaxel) along with immunotherapy.
Nab-Paclitaxel
Specified dose on specified days. Participant will receive only two of the listed chemotherapies (carboplatin, cisplatin, paclitaxel, nab-paclitaxel) along with immunotherapy.
Pemetrexed
Specified dose on specified days. Participant will receive only two of the listed chemotherapies (carboplatin, cisplatin, paclitaxel, nab-paclitaxel) along with immunotherapy.
Local Institution - 0079, Santiago
Local Institution - 0133, Elm Park
Local Institution - 0126, Vienna
Local Institution - 0029, Rosario
Local Institution - 0055, Camperdown
Local Institution - 0086, Gosford
Local Institution - 0132, Tamworth
Local Institution - 0141, Box Hill
Local Institution - 0109, Frankston
Local Institution - 0130, Ballarat
Local Institution - 0138, Bendigo
Local Institution - 0053, Harderwijk
Local Institution - 0015, Basel
Local Institution - 0060, Córdoba
Local Institution - 0057, Adelaide
Local Institution - 0037, Río Cuarto
Local Institution - 0085, Nedlands
Local Institution - 0119, Murdoch
Local Institution - 0158, Arnhem
Local Institution - 0090, Graz
Local Institution - 0039, Viedma
Local Institution - 0125, Roeselare
Local Institution - 0127, Ghent
Local Institution - 0131, Ghent
Local Institution - 0104, Sankt Gallen
Local Institution - 0128, New York
Local Institution - 0165, New York
Local Institution - 0028, Candiolo
Local Institution - 0097, The Bronx
Local Institution - 0162, Mineola
Local Institution - 0103, Berlin
Local Institution - 0045, Berlin
Local Institution - 0124, Johnson City
Local Institution - 0070, Mexico City
Local Institution - 0051, A Coruña
Local Institution - 0147, Pittsburgh
Local Institution - 0032, Genova
Local Institution - 0084, Lancaster
Local Institution - 0059, Milan
Local Institution - 0062, Großhansdorf
Local Institution - 0157, Morgantown
Local Institution - 0117, Durham
Local Institution - 0074, Madrid
Local Institution - 0123, Madrid
Local Institution - 0042, Málaga
Local Institution - 0083, Greenville
Local Institution - 0089, Athens
Local Institution - 0153, Jacksonville
Local Institution - 0050, Paderborn
Local Institution - 0011, Port Saint Lucie
Local Institution - 0008, Rennes
Local Institution - 0061, Las Palmas
Local Institution - 0071, Marburg
Local Institution - 0002, Louisville
Local Institution - 0159, Lexington
Local Institution - 0075, Seville
Local Institution - 0155, Cleveland
Local Institution - 0065, Essen
Local Institution - 0156, Cincinnati
Local Institution - 0043, Valencia
Local Institution - 0020, Toluca
Local Institution - 0019, Siena
Local Institution - 0164, Pesaro
Local Institution - 0115, Monterrey
Local Institution - 0013, San Pedro Garza García
Local Institution - 0058, Homburg
Local Institution - 0121, Wichita
Local Institution - 0129, Omaha
Local Institution - 0144, Le Mans
Local Institution - 0108, Löwenstein
Local Institution - 0110, Paris
Local Institution - 0102, Paris
Local Institution - 0035, Paris
Local Institution - 0001, Tyler
Local Institution - 0091, Harlingen
Local Institution - 0030, Ravensburg
Local Institution - 0160, Duarte
Local Institution - 0081, Orange
Local Institution - 0006, Saint-Mandé
Local Institution - 0009, Catania
Local Institution - 0092, Spokane
Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk
LLC Eurocityclinic, Saint Petersburg
FSBI ",Research Institute of Influenza named after A.A. Smorodintsev ",of the MoH of the Rus, Saint Petersburg
Local Institution - 0012, Craiova
Local Institution - 0052, Craiova
Local Institution - 0017, Craiova
Local Institution - 0069, Timișoara
Local Institution - 0099, Cluj-Napoca
Local Institution - 0041, Santiago
Local Institution - 0016, Santiago
Local Institution - 0139, New Haven
Local Institution - 0082, Scarborough
Local Institution - 0152, Howell Township
Local Institution - 0148, Providence
Local Institution - 0149, Dallas
Local Institution - 0021, Buenos Aires
Local Institution - 0014, Cuiudad Autonoma de Buenos Aires
Local Institution - 0038, Córdoba
Local Institution - 0073, La Rioja
Local Institution - 0063, Natal
Local Institution - 0161, Ijuí
Local Institution - 0116, Porto Alegre
Local Institution - 0112, Porto Alegre
Local Institution - 0107, Barretos
Local Institution - 0111, Santo André
Local Institution - 0072, Rio de Janeiro
Local Institution - 0163, São Paulo
Local Institution - 0120, São Paulo
Local Institution - 0007, Dijon
Local Institution - 0023, Dublin
Local Institution - 0106, Rome
Local Institution - 0145, Gdynia
Local Institution - 0036, Lublin
Local Institution - 0031, Lublin
Local Institution - 0080, Olsztyn
Local Institution - 0088, Warsaw
Local Institution - 0137, Badalona
Local Institution - 0024, Barcelona
Local Institution - 0154, Barcelona
Local Institution - 0048, Barcelona
Local Institution - 0135, Middlesbrough
Local Institution - 0101, London
Local Institution - 0095, Manchester
Local Institution - 0067, Leicester
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY